Spiriva (tiotropium) inhalation via Respimat
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Spiriva (tiotropium) inhalation via Respimat, covering 2015-06-23 to 2015-06-23. Get the full timeline:
Most recent: Clinical Trial Update: Evaluation of Tiotropium 2.5 and 5 mcg Once Daily Delivered Via the Respimat® Inhaler Compared to Placebo in 1 to 5 Year Old Patients With Persistent Asthma [Phase 2]